InvestorsHub Logo
Followers 84
Posts 12487
Boards Moderated 0
Alias Born 07/25/2008

Re: greggors post# 13073

Tuesday, 08/03/2021 4:48:44 PM

Tuesday, August 03, 2021 4:48:44 PM

Post# of 17477
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
PUBLISHED
2 August 2021
2 August 2021 07:00 BST


Saphnelo is a first-in-class type I interferon receptor antibody and the only new medicine in over a decade for patients with systemic lupus erythematosus

I think this will be big in SLE. Remember, if you can suppress SLE, LN cases will be Drastically reduced..
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News